Department of Neurosciences, Division of Neuroscience Research, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Mol Pharmacol. 2012 Jan;81(1):73-85. doi: 10.1124/mol.111.073171. Epub 2011 Oct 12.
The serotonin (5-HT) transporter (SERT) regulates serotoninergic neurotransmission by clearing 5-HT released into the synaptic space. Phosphorylation of SERT on serine and threonine mediates SERT regulation. Whether tyrosine phosphorylation regulates SERT is unknown. Here, we tested the hypothesis that tyrosine-phosphorylation of SERT regulates 5-HT transport. In support of this, alkali-resistant (32)P-labeled SERT was found in rat platelets, and Src-tyrosine kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo [3,4,d]pyrimidine (PP2) decreased platelet SERT function and expression. In human placental trophoblast cells expressing SERT, PP2 reduced transporter function, expression, and stability. Although siRNA silencing of Src expression decreased SERT function and expression, coexpression of Src resulted in PP2-sensitive increases in SERT function and expression. PP2 treatment markedly decreased SERT protein stability. Compared with WT-SERT, SERT tyrosine mutants Y47F and Y142F exhibited reduced 5-HT transport despite their higher total and cell surface expression levels. Moreover, Src-coexpression increased total and cell surface expression of Y47F and Y142F SERT mutants without affecting their 5-HT transport capacity. It is noteworthy that Y47F and Y142F mutants exhibited higher protein stability compared with WT-SERT. However, similar to WT-SERT, PP2 treatment decreased the stability of Y47F and Y142F mutants. Furthermore, compared with WT-SERT, Y47F and Y142F mutants exhibited lower basal tyrosine phosphorylation and no further enhancement of tyrosine phosphorylation in response to Src coexpression. These results provide the first evidence that SERT tyrosine phosphorylation supports transporter protein stability and 5HT transport.
5-羟色胺(5-HT)转运体(SERT)通过清除释放到突触间隙的 5-HT 来调节 5-HT 能神经传递。SERT 的丝氨酸和苏氨酸磷酸化介导 SERT 调节。酪氨酸磷酸化是否调节 SERT 尚不清楚。在这里,我们测试了 SERT 酪氨酸磷酸化调节 5-HT 转运的假设。支持这一观点的是,在大鼠血小板中发现了耐碱(32)P 标记的 SERT,Src 酪氨酸激酶抑制剂 4-氨基-5-(4-氯苯基)-7-(叔丁基)吡唑并[3,4,d]嘧啶(PP2)降低了血小板 SERT 功能和表达。在表达 SERT 的人胎盘滋养层细胞中,PP2 降低了转运蛋白的功能、表达和稳定性。尽管 Src 表达的 siRNA 沉默降低了 SERT 的功能和表达,但 Src 的共表达导致 SERT 功能和表达的 PP2 敏感增加。PP2 处理显著降低了 SERT 蛋白稳定性。与 WT-SERT 相比,尽管 Y47F 和 Y142F SERT 突变体的总表达和细胞表面表达水平较高,但 5-HT 转运减少。此外,Src 共表达增加了 Y47F 和 Y142F SERT 突变体的总表达和细胞表面表达,而不影响其 5-HT 转运能力。值得注意的是,与 WT-SERT 相比,Y47F 和 Y142F 突变体表现出更高的蛋白质稳定性。然而,与 WT-SERT 相似,PP2 处理降低了 Y47F 和 Y142F 突变体的稳定性。此外,与 WT-SERT 相比,Y47F 和 Y142F 突变体表现出较低的基础酪氨酸磷酸化,并且 Src 共表达没有进一步增强酪氨酸磷酸化。这些结果首次提供了证据,表明 SERT 酪氨酸磷酸化支持转运蛋白的稳定性和 5-HT 转运。